Advanced search
1 file | 1.13 MB Add to list

Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults

(2010) CLINICAL AND VACCINE IMMUNOLOGY. 17(11). p.1763-1771
Author
Organization
Keywords
TUMOR-NECROSIS-FACTOR, MYCOBACTERIUM-TUBERCULOSIS, CD8(+) T-CELLS, POLYPROTEIN VACCINE, MEDIATED IMMUNITY, HEALTHY-ADULTS, RESPONSES, CD4(+), BCG, HUMANS

Downloads

  • LerouxRoels 2010 CVI 17 11 1763.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 1.13 MB

Citation

Please use this url to cite or link to this publication:

MLA
Leroux-Roels, Isabel, Geert Leroux-Roels, Opokua Ofori-Anyinam, et al. “Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-negative Adults.” CLINICAL AND VACCINE IMMUNOLOGY 17.11 (2010): 1763–1771. Print.
APA
Leroux-Roels, I., Leroux-Roels, G., Ofori-Anyinam, O., Moris, P., De Kock, E., Clement, F., Dubois, M.-C., et al. (2010). Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults. CLINICAL AND VACCINE IMMUNOLOGY, 17(11), 1763–1771.
Chicago author-date
Leroux-Roels, Isabel, Geert Leroux-Roels, Opokua Ofori-Anyinam, Philippe Moris, Els De Kock, Frédéric Clement, Marie-Claude Dubois, et al. 2010. “Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-negative Adults.” Clinical and Vaccine Immunology 17 (11): 1763–1771.
Chicago author-date (all authors)
Leroux-Roels, Isabel, Geert Leroux-Roels, Opokua Ofori-Anyinam, Philippe Moris, Els De Kock, Frédéric Clement, Marie-Claude Dubois, Marguerite Koutsoukos, Marie-Ange Demoitie, Joe Cohen, and W Ripley Ballou. 2010. “Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-negative Adults.” Clinical and Vaccine Immunology 17 (11): 1763–1771.
Vancouver
1.
Leroux-Roels I, Leroux-Roels G, Ofori-Anyinam O, Moris P, De Kock E, Clement F, et al. Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults. CLINICAL AND VACCINE IMMUNOLOGY. 2010;17(11):1763–71.
IEEE
[1]
I. Leroux-Roels et al., “Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults,” CLINICAL AND VACCINE IMMUNOLOGY, vol. 17, no. 11, pp. 1763–1771, 2010.
@article{1231175,
  author       = {Leroux-Roels, Isabel and Leroux-Roels, Geert and Ofori-Anyinam, Opokua and Moris, Philippe and De Kock, Els and Clement, Frédéric and Dubois, Marie-Claude and Koutsoukos, Marguerite and Demoitie, Marie-Ange and Cohen, Joe and Ballou, W Ripley},
  issn         = {1556-6811},
  journal      = {CLINICAL AND VACCINE IMMUNOLOGY},
  keywords     = {TUMOR-NECROSIS-FACTOR,MYCOBACTERIUM-TUBERCULOSIS,CD8(+) T-CELLS,POLYPROTEIN VACCINE,MEDIATED IMMUNITY,HEALTHY-ADULTS,RESPONSES,CD4(+),BCG,HUMANS},
  language     = {eng},
  number       = {11},
  pages        = {1763--1771},
  title        = {Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults},
  url          = {http://dx.doi.org/10.1128/CVI.00133-10},
  volume       = {17},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: